Introduction of Harvard Wyss Diagnostics Accelerator and the Industrial Participant Programs with Dr. Rushdy Ahmad
We are pleased to invite you to attend our Q Bay Mentor Series Talk, which will be held on the 31 of August 2021 at 06:00 pm PT. This time we invited the head of Harvard Wyss Diagnostics Accelerator (DxA), Dr. Rushdy Ahmad for an introduction of Wyss Diagnostics Accelerator and the Industrial Participant Programs.
The mission of Harvard Wyss Diagnostics Accelerator is to ultimately save lives by accelerating the development and deployment of needed diagnostics. It formed as a multifaceted collaboration between clinicians, researchers, engineers, funding agencies, philanthropists, government agencies, and industry partners. These partners work together to transfer technology from bench to bedside.
Date & Time: August 31, 2021
06:00 pm – 07:00 pm, August 31 (PDT)
09:00 pm – 10:00 pm, August 31 (EDT)
09:00 am – 10:00 am, September 1 (GMT+8, Beijing)
Venue: Zoom for All participants
We are planning to invite companies in Q Bay community, VCs, industrial partners, incubators, accelerators and associations to participate in the event. It will be an online event hosted on Zoom. If you are interested, please click the registration button or send the registration request to email@example.com. In order to ensure the quality of the event, we need your registration information before sending you the Zoom link. The deadline for registration is August 27.
Dr. Rushdy Ahmad has over 16 years of experience as a biomarker hunter with the goal of translating the biomarkers into lifesaving diagnostics that deliver outcome and save lives. Therefore, it’s quite natural that he now comes to the Wyss to help lead and promote the Diagnostics Accelerator. Prior to this he was a neutrino hunter as an experimental physicist and helped solve the long-standing solar neutrino problem which garnered his project director, Art MacDonald, the 2015 Nobel Prize in Physics. But leaving a potentially promising career in physics wasn’t difficult because of his growing desire to help people in need of life saving interventions. To this end, he was able to hone his skills in biomarker discovery and diagnostics as a post-doctoral fellow at Boston University School of Medicine and then at the Broad Institute of MIT and Harvard, where he practiced clinical proteomics and biomarker discovery in all types of diseases for 12 years. In between academic careers he worked in the software industry, built companies and charitable organizations, while never forgetting to dedicate time and resource to serving the underserved, the underprivileged, the disenfranchised. Therefore, his mission at the Wyss is clear, since it’s indeed a privilege to be here and with that privilege comes great responsibility to deliver outcome to those who need it. He joined the Wyss few days before the COVID-19 shutdown and was able to jump into the worldwide battle and effectively lead the direct-to-consumer (DTC) diagnostics working group for the Mass General Brigham Center for COVID Innovation (MGBCCI). Rushdy received his PhD from Brown University.